Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 14 entries
Sorted by: Best Match Show Resources per page
The effect of vitamin C on bronchoconstriction and respiratory symptoms caused by exercise: a review and statistical analysis.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Hemilä H.
PMID: 25788952
Allergy Asthma Clin Immunol. 2014 Nov 27;10(1):58. doi: 10.1186/1710-1492-10-58. eCollection 2014.

Physical activity increases oxidative stress and therefore the antioxidant effects of vitamin C administration might become evident in people undertaking vigorous exercise. Vitamin C is involved in the metabolism of histamine, prostaglandins, and cysteinyl leukotrienes, all of which appear...

Cite
Hemilä H. The effect of vitamin C on bronchoconstriction and respiratory symptoms caused by exercise: a review and statistical analysis. Allergy Asthma Clin Immunol. 2014;10(1):58doi: 10.1186/1710-1492-10-58.
Hemilä, H. (2014). The effect of vitamin C on bronchoconstriction and respiratory symptoms caused by exercise: a review and statistical analysis. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 10(1), 58. https://doi.org/10.1186/1710-1492-10-58
Hemilä, Harri. "The effect of vitamin C on bronchoconstriction and respiratory symptoms caused by exercise: a review and statistical analysis." Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology vol. 10,1 (2014): 58. doi: https://doi.org/10.1186/1710-1492-10-58
Hemilä H. The effect of vitamin C on bronchoconstriction and respiratory symptoms caused by exercise: a review and statistical analysis. Allergy Asthma Clin Immunol. 2014 Nov 27;10(1):58. doi: 10.1186/1710-1492-10-58. eCollection 2014. PMID: 25788952; PMCID: PMC4363347.
Copy Download .nbib Format: NLM
Intern prescribing decisions: few and far between.

Education for health (Abingdon, England)

Pearson SA, Rolfe I, Smith T, O'Connell D.
PMID: 14741939
Educ Health (Abingdon). 2002;15(3):315-25. doi: 10.1080/1357628021000012868.

OBJECTIVE: To examine the scope of intern prescribing practices by determining: the proportion of prescriptions that interns chart compared with other medical staff; the proportion of intern-charted prescriptions for which interns are sole decision-makers; whether or not intern-initiated prescribing...

Cite
Pearson SA, Rolfe I, Smith T, et al. Intern prescribing decisions: few and far between. Educ Health (Abingdon). 2002;15(3):315-25doi: 10.1080/1357628021000012868.
Pearson, S. A., Rolfe, I., Smith, T., & O'Connell, D. (2002). Intern prescribing decisions: few and far between. Education for health (Abingdon, England), 15(3), 315-25. https://doi.org/10.1080/1357628021000012868
Pearson, Sallie-Anne, et al. "Intern prescribing decisions: few and far between." Education for health (Abingdon, England) vol. 15,3 (2002): 315-25. doi: https://doi.org/10.1080/1357628021000012868
Pearson SA, Rolfe I, Smith T, O'Connell D. Intern prescribing decisions: few and far between. Educ Health (Abingdon). 2002;15(3):315-25. doi: 10.1080/1357628021000012868. PMID: 14741939.
Copy Download .nbib Format: NLM
Utilization, spending, and price trends for short- and long-acting Beta-agonists and inhaled corticosteroids in the medicaid program, 1991-2010.

American health & drug benefits

Chiu SF, Kelton CM, Guo JJ, Wigle PR, Lin AC, Szeinbach SL.
PMID: 25126346
Am Health Drug Benefits. 2011 May;4(3):140-9.

BACKGROUND: Asthma is a chronic respiratory disease that afflicts millions of people and accounts for substantial utilization of healthcare resources in most industrialized countries, including in the United States. However, the exact cost and utilization of anti-asthma medications in...

Cite
Chiu SF, Kelton CM, Guo JJ, et al. Utilization, spending, and price trends for short- and long-acting Beta-agonists and inhaled corticosteroids in the medicaid program, 1991-2010. Am Health Drug Benefits. 2011;4(3):140-9
Chiu, S. F., Kelton, C. M., Guo, J. J., Wigle, P. R., Lin, A. C., & Szeinbach, S. L. (2011). Utilization, spending, and price trends for short- and long-acting Beta-agonists and inhaled corticosteroids in the medicaid program, 1991-2010. American health & drug benefits, 4(3), 140-9.
Chiu, Shih-Feng, et al. "Utilization, spending, and price trends for short- and long-acting Beta-agonists and inhaled corticosteroids in the medicaid program, 1991-2010." American health & drug benefits vol. 4,3 (2011): 140-9.
Chiu SF, Kelton CM, Guo JJ, Wigle PR, Lin AC, Szeinbach SL. Utilization, spending, and price trends for short- and long-acting Beta-agonists and inhaled corticosteroids in the medicaid program, 1991-2010. Am Health Drug Benefits. 2011 May;4(3):140-9. PMID: 25126346; PMCID: PMC4105711.
Copy Download .nbib Format: NLM
Epigenetic regulation in allergic diseases and related studies.

Asia Pacific allergy

Kuo CH, Hsieh CC, Lee MS, Chang KT, Kuo HF, Hung CH.
PMID: 24527405
Asia Pac Allergy. 2014 Jan;4(1):14-8. doi: 10.5415/apallergy.2014.4.1.14. Epub 2014 Jan 31.

Asthma, a chronic inflammatory disorder of the airway, has features of both heritability as well as environmental influences which can be introduced in utero exposures and modified through aging, and the features may attribute to epigenetic regulation. Epigenetic regulation...

Cite
Kuo CH, Hsieh CC, Lee MS, et al. Epigenetic regulation in allergic diseases and related studies. Asia Pac Allergy. 2014;4(1):14-8doi: 10.5415/apallergy.2014.4.1.14.
Kuo, C. H., Hsieh, C. C., Lee, M. S., Chang, K. T., Kuo, H. F., & Hung, C. H. (2014). Epigenetic regulation in allergic diseases and related studies. Asia Pacific allergy, 4(1), 14-8. https://doi.org/10.5415/apallergy.2014.4.1.14
Kuo, Chang-Hung, et al. "Epigenetic regulation in allergic diseases and related studies." Asia Pacific allergy vol. 4,1 (2014): 14-8. doi: https://doi.org/10.5415/apallergy.2014.4.1.14
Kuo CH, Hsieh CC, Lee MS, Chang KT, Kuo HF, Hung CH. Epigenetic regulation in allergic diseases and related studies. Asia Pac Allergy. 2014 Jan;4(1):14-8. doi: 10.5415/apallergy.2014.4.1.14. Epub 2014 Jan 31. PMID: 24527405; PMCID: PMC3921865.
Copy Download .nbib Format: NLM
Relationship Between Different Types and Forms of Anti-Asthmatic Medications and Dental Caries in Three to 12 Year Olds.

Journal of dentistry (Tehran, Iran)

Heidari A, Seraj B, Shahrabi M, Maghsoodi H, Kharazifard MJ, Zarabian T.
PMID: 28127315
J Dent (Tehran). 2016 Aug;13(4):238-243.

OBJECTIVES: Asthma is a common chronic disease. Asthma and anti-asthmatic medications have been suggested as risk factors for increased susceptibility to caries. This study was conducted to evaluate the effects of different types and forms of antihistaminic medications and...

Cite
Heidari A, Seraj B, Shahrabi M, et al. Relationship Between Different Types and Forms of Anti-Asthmatic Medications and Dental Caries in Three to 12 Year Olds. J Dent (Tehran). 2016;13(4):238-243
Heidari, A., Seraj, B., Shahrabi, M., Maghsoodi, H., Kharazifard, M. J., & Zarabian, T. (2016). Relationship Between Different Types and Forms of Anti-Asthmatic Medications and Dental Caries in Three to 12 Year Olds. Journal of dentistry (Tehran, Iran), 13(4), 238-243.
Heidari, Alireza, et al. "Relationship Between Different Types and Forms of Anti-Asthmatic Medications and Dental Caries in Three to 12 Year Olds." Journal of dentistry (Tehran, Iran) vol. 13,4 (2016): 238-243.
Heidari A, Seraj B, Shahrabi M, Maghsoodi H, Kharazifard MJ, Zarabian T. Relationship Between Different Types and Forms of Anti-Asthmatic Medications and Dental Caries in Three to 12 Year Olds. J Dent (Tehran). 2016 Aug;13(4):238-243. PMID: 28127315; PMCID: PMC5253216.
Copy Download .nbib Format: NLM
Clinical Impact of a Digital Dose Counter Pressurized Metered-Dose Inhaler on Uncontrolled Asthma: Cross-Sectional, Observational, Surveillance Study.

Interactive journal of medical research

Guleria R, Korukonda K.
PMID: 31066694
Interact J Med Res. 2019 May 05;8(2):e13530. doi: 10.2196/13530.

BACKGROUND: In India, control of asthma with persistent symptoms remains a clinical enigma with likely incriminating factors including non- and pseudoadherence to the inhaled corticosteroids and long-acting beta2-agonists. The United States Food and Drug Administration guidance recommends the use...

Cite
Guleria R, Korukonda K. Clinical Impact of a Digital Dose Counter Pressurized Metered-Dose Inhaler on Uncontrolled Asthma: Cross-Sectional, Observational, Surveillance Study. Interact J Med Res. 2019;8(2):e13530doi: 10.2196/13530.
Guleria, R., Korukonda, K. (2019). Clinical Impact of a Digital Dose Counter Pressurized Metered-Dose Inhaler on Uncontrolled Asthma: Cross-Sectional, Observational, Surveillance Study. Interactive journal of medical research, 8(2), e13530. https://doi.org/10.2196/13530
Guleria, Randeep, et al. "Clinical Impact of a Digital Dose Counter Pressurized Metered-Dose Inhaler on Uncontrolled Asthma: Cross-Sectional, Observational, Surveillance Study." Interactive journal of medical research vol. 8,2 (2019): e13530. doi: https://doi.org/10.2196/13530
Guleria R, Korukonda K. Clinical Impact of a Digital Dose Counter Pressurized Metered-Dose Inhaler on Uncontrolled Asthma: Cross-Sectional, Observational, Surveillance Study. Interact J Med Res. 2019 May 05;8(2):e13530. doi: 10.2196/13530. PMID: 31066694; PMCID: PMC6528432.
Copy Download .nbib Format: NLM
Choice of add-on therapy in asthma - another inhaler or a tablet/syrup? A survey of 1415 UK asthmatics.

Primary care respiratory journal : journal of the General Practice Airways Group

Tuggey J, Hosker HSR, Chetcuti P, Brownlee K, Taylor J, MacGowan C.
PMID: 31700272
Prim Care Respir J. 2001 Jun;10(2):27-30. doi: 10.1038/pcrj.2001.9. Epub 2001 Jun 01.

OBJECTIVES: To determine preferences for asthma treatment given as inhaled therapy or as a tablet / syrup, to identify factors that influence this choice, and to assess how many patients would sacrifice greater efficacy of therapy in order to...

Cite
Tuggey J, Hosker HSR, Chetcuti P, et al. Choice of add-on therapy in asthma - another inhaler or a tablet/syrup? A survey of 1415 UK asthmatics. Prim Care Respir J. 2001;10(2):27-30doi: 10.1038/pcrj.2001.9.
Tuggey, J., Hosker, H. S. R., Chetcuti, P., Brownlee, K., Taylor, J., & MacGowan, C. (2001). Choice of add-on therapy in asthma - another inhaler or a tablet/syrup? A survey of 1415 UK asthmatics. Primary care respiratory journal : journal of the General Practice Airways Group, 10(2), 27-30. https://doi.org/10.1038/pcrj.2001.9
Tuggey, J, et al. "Choice of add-on therapy in asthma - another inhaler or a tablet/syrup? A survey of 1415 UK asthmatics." Primary care respiratory journal : journal of the General Practice Airways Group vol. 10,2 (2001): 27-30. doi: https://doi.org/10.1038/pcrj.2001.9
Tuggey J, Hosker HSR, Chetcuti P, Brownlee K, Taylor J, MacGowan C. Choice of add-on therapy in asthma - another inhaler or a tablet/syrup? A survey of 1415 UK asthmatics. Prim Care Respir J. 2001 Jun;10(2):27-30. doi: 10.1038/pcrj.2001.9. Epub 2001 Jun 01. PMID: 31700272; PMCID: PMC6812079.
Copy Download .nbib Format: NLM
Today's improvement in asthma treatment: role of MART and Easyhaler.

Multidisciplinary respiratory medicine

Di Marco F.
PMID: 32983452
Multidiscip Respir Med. 2020 Aug 05;15(1):649. doi: 10.4081/mrm.2020.649. eCollection 2020 Jan 28.

Asthma affects more than 330 million people worldwide, but many analyses have shown that there are still a lot of unmet needs for both patients and physicians in the treatment of asthma: poor adherence to treatment is one of...

Cite
Di Marco F. Today's improvement in asthma treatment: role of MART and Easyhaler. Multidiscip Respir Med. 2020;15(1):649doi: 10.4081/mrm.2020.649.
Di Marco, F. (2020). Today's improvement in asthma treatment: role of MART and Easyhaler. Multidisciplinary respiratory medicine, 15(1), 649. https://doi.org/10.4081/mrm.2020.649
Di Marco, Fabiano. "Today's improvement in asthma treatment: role of MART and Easyhaler." Multidisciplinary respiratory medicine vol. 15,1 (2020): 649. doi: https://doi.org/10.4081/mrm.2020.649
Di Marco F. Today's improvement in asthma treatment: role of MART and Easyhaler. Multidiscip Respir Med. 2020 Aug 05;15(1):649. doi: 10.4081/mrm.2020.649. eCollection 2020 Jan 28. PMID: 32983452; PMCID: PMC7460660.
Copy Download .nbib Format: NLM
Mast cell tryptase and asthma.

Mediators of inflammation

Zhang MQ, Timmerman H.
PMID: 18472864
Mediators Inflamm. 1997;6(5):311-7. doi: 10.1080/09629359791433.

Recent physiological and pharmacological studies have indicated the potential importance of tryptase, the major protein component in mast cells, in inflammatory diseases (especially asthma). Being released at inflammatory sites after the activation of mast cells, tryptase is capable of...

Cite
Zhang MQ, Timmerman H. Mast cell tryptase and asthma. Mediators Inflamm. 1997;6(5):311-7doi: 10.1080/09629359791433.
Zhang, M. Q., & Timmerman, H. (1997). Mast cell tryptase and asthma. Mediators of inflammation, 6(5), 311-7. https://doi.org/10.1080/09629359791433
Zhang, M Q, and Timmerman, H. "Mast cell tryptase and asthma." Mediators of inflammation vol. 6,5 (1997): 311-7. doi: https://doi.org/10.1080/09629359791433
Zhang MQ, Timmerman H. Mast cell tryptase and asthma. Mediators Inflamm. 1997;6(5):311-7. doi: 10.1080/09629359791433. PMID: 18472864; PMCID: PMC2365873.
Copy Download .nbib Format: NLM
Synthesis and in vitro evaluation of anti-inflammatory, antioxidant, and anti-fibrotic effects of new 8-aminopurine-2,6-dione-based phosphodiesterase inhibitors as promising anti-asthmatic agents.

Bioorganic chemistry

Wójcik-Pszczoła K, Jankowska A, Ślusarczyk M, Jakieła B, Plutecka H, Pociecha K, Świerczek A, Popiół J, Koczurkiewicz-Adamczyk P, Wyska E, Pękala E, Gosens R, Chłoń-Rzepa G.
PMID: 34749117
Bioorg Chem. 2021 Dec;117:105409. doi: 10.1016/j.bioorg.2021.105409. Epub 2021 Oct 16.

Phosphodiesterase (PDE) inhibitors are currently an extensively studied group of compounds that can bring many benefits in the treatment of various inflammatory and fibrotic diseases, including asthma. Herein, we describe a series of novel N'-phenyl- or N'-benzylbutanamide and N'-arylidenebutanehydrazide...

Cite
Wójcik-Pszczoła K, Jankowska A, Ślusarczyk M, et al. Synthesis and in vitro evaluation of anti-inflammatory, antioxidant, and anti-fibrotic effects of new 8-aminopurine-2,6-dione-based phosphodiesterase inhibitors as promising anti-asthmatic agents. Bioorg Chem. 2021;117:105409doi: 10.1016/j.bioorg.2021.105409.
Wójcik-Pszczoła, K., Jankowska, A., Ślusarczyk, M., Jakieła, B., Plutecka, H., Pociecha, K., Świerczek, A., Popiół, J., Koczurkiewicz-Adamczyk, P., Wyska, E., Pękala, E., Gosens, R., & Chłoń-Rzepa, G. (2021). Synthesis and in vitro evaluation of anti-inflammatory, antioxidant, and anti-fibrotic effects of new 8-aminopurine-2,6-dione-based phosphodiesterase inhibitors as promising anti-asthmatic agents. Bioorganic chemistry, 117105409. https://doi.org/10.1016/j.bioorg.2021.105409
Wójcik-Pszczoła, Katarzyna, et al. "Synthesis and in vitro evaluation of anti-inflammatory, antioxidant, and anti-fibrotic effects of new 8-aminopurine-2,6-dione-based phosphodiesterase inhibitors as promising anti-asthmatic agents." Bioorganic chemistry vol. 117 (2021): 105409. doi: https://doi.org/10.1016/j.bioorg.2021.105409
Wójcik-Pszczoła K, Jankowska A, Ślusarczyk M, Jakieła B, Plutecka H, Pociecha K, Świerczek A, Popiół J, Koczurkiewicz-Adamczyk P, Wyska E, Pękala E, Gosens R, Chłoń-Rzepa G. Synthesis and in vitro evaluation of anti-inflammatory, antioxidant, and anti-fibrotic effects of new 8-aminopurine-2,6-dione-based phosphodiesterase inhibitors as promising anti-asthmatic agents. Bioorg Chem. 2021 Dec;117:105409. doi: 10.1016/j.bioorg.2021.105409. Epub 2021 Oct 16. PMID: 34749117.
Copy Download .nbib Format: NLM
Synthesis and in vitro evaluation of anti-inflammatory, antioxidant, and anti-fibrotic effects of new 8-aminopurine-2,6-dione-based phosphodiesterase inhibitors as promising anti-asthmatic agents.

Bioorganic chemistry

Wójcik-Pszczoła K, Jankowska A, Ślusarczyk M, Jakieła B, Plutecka H, Pociecha K, Świerczek A, Popiół J, Koczurkiewicz-Adamczyk P, Wyska E, Pękala E, Gosens R, Chłoń-Rzepa G.
PMID: 34749117
Bioorg Chem. 2021 Dec;117:105409. doi: 10.1016/j.bioorg.2021.105409. Epub 2021 Oct 16.

Phosphodiesterase (PDE) inhibitors are currently an extensively studied group of compounds that can bring many benefits in the treatment of various inflammatory and fibrotic diseases, including asthma. Herein, we describe a series of novel N'-phenyl- or N'-benzylbutanamide and N'-arylidenebutanehydrazide...

Cite
Wójcik-Pszczoła K, Jankowska A, Ślusarczyk M, et al. Synthesis and in vitro evaluation of anti-inflammatory, antioxidant, and anti-fibrotic effects of new 8-aminopurine-2,6-dione-based phosphodiesterase inhibitors as promising anti-asthmatic agents. Bioorg Chem. 2021;117:105409doi: 10.1016/j.bioorg.2021.105409.
Wójcik-Pszczoła, K., Jankowska, A., Ślusarczyk, M., Jakieła, B., Plutecka, H., Pociecha, K., Świerczek, A., Popiół, J., Koczurkiewicz-Adamczyk, P., Wyska, E., Pękala, E., Gosens, R., & Chłoń-Rzepa, G. (2021). Synthesis and in vitro evaluation of anti-inflammatory, antioxidant, and anti-fibrotic effects of new 8-aminopurine-2,6-dione-based phosphodiesterase inhibitors as promising anti-asthmatic agents. Bioorganic chemistry, 117105409. https://doi.org/10.1016/j.bioorg.2021.105409
Wójcik-Pszczoła, Katarzyna, et al. "Synthesis and in vitro evaluation of anti-inflammatory, antioxidant, and anti-fibrotic effects of new 8-aminopurine-2,6-dione-based phosphodiesterase inhibitors as promising anti-asthmatic agents." Bioorganic chemistry vol. 117 (2021): 105409. doi: https://doi.org/10.1016/j.bioorg.2021.105409
Wójcik-Pszczoła K, Jankowska A, Ślusarczyk M, Jakieła B, Plutecka H, Pociecha K, Świerczek A, Popiół J, Koczurkiewicz-Adamczyk P, Wyska E, Pękala E, Gosens R, Chłoń-Rzepa G. Synthesis and in vitro evaluation of anti-inflammatory, antioxidant, and anti-fibrotic effects of new 8-aminopurine-2,6-dione-based phosphodiesterase inhibitors as promising anti-asthmatic agents. Bioorg Chem. 2021 Dec;117:105409. doi: 10.1016/j.bioorg.2021.105409. Epub 2021 Oct 16. PMID: 34749117.
Copy Download .nbib Format: NLM
Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids.

Allergy, asthma & immunology research

Postma DS, Dekhuijzen R, van der Molen T, Martin RJ, van Aalderen W, Roche N, Guilbert TW, Israel E, van Eickels D, Khalid JM, Herings RM, Overbeek JA, Miglio C, Thomas V, Hutton C, Hillyer EV, Price DB.
PMID: 28102056
Allergy Asthma Immunol Res. 2017 Mar;9(2):116-125. doi: 10.4168/aair.2017.9.2.116.

PURPOSE: Extrafine-particle inhaled corticosteroids (ICS) have greater small airway deposition than standard fine-particle ICS. We sought to compare asthma-related outcomes after patients initiated extrafine-particle ciclesonide or fine-particle ICS (fluticasone propionate or non-extrafine beclomethasone).METHODS: This historical, matched cohort study included...

Cite
Postma DS, Dekhuijzen R, van der Molen T, et al. Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids. Allergy Asthma Immunol Res. 2017;9(2):116-125doi: 10.4168/aair.2017.9.2.116.
Postma, D. S., Dekhuijzen, R., van der Molen, T., Martin, R. J., van Aalderen, W., Roche, N., Guilbert, T. W., Israel, E., van Eickels, D., Khalid, J. M., Herings, R. M., Overbeek, J. A., Miglio, C., Thomas, V., Hutton, C., Hillyer, E. V., & Price, D. B. (2017). Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids. Allergy, asthma & immunology research, 9(2), 116-125. https://doi.org/10.4168/aair.2017.9.2.116
Postma, Dirkje S, et al. "Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids." Allergy, asthma & immunology research vol. 9,2 (2017): 116-125. doi: https://doi.org/10.4168/aair.2017.9.2.116
Postma DS, Dekhuijzen R, van der Molen T, Martin RJ, van Aalderen W, Roche N, Guilbert TW, Israel E, van Eickels D, Khalid JM, Herings RM, Overbeek JA, Miglio C, Thomas V, Hutton C, Hillyer EV, Price DB. Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids. Allergy Asthma Immunol Res. 2017 Mar;9(2):116-125. doi: 10.4168/aair.2017.9.2.116. PMID: 28102056; PMCID: PMC5266109.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 14 entries